FierceBiotech· @FierceBiotech · X·· 9 天前精选AI 评分65
AI 导读
中国计划在五年内使首创药物（first-in-class）占比至少达到25%，以巩固其在创新研发领域的地位。该目标出自一项新的五年规划，相关报道链接为 https://www.fiercebiotech.com/biotech/china-targets-25-share-global-first-class-drugs-new-5-year-plan。
推荐理由
中国五年规划提出首创药物占比目标，读者可据此了解其在全球创新研发中的定位意图。
正文
China is aiming to account for at least 25% of first-in-class drugs as part of a five-year push to cement its emerging status in innovative R&D. https://www.fiercebiotech.com/biotech/china-targets-25-share-global-first-class-drugs-new-5-year-plan
来源：FierceBiotech · x.com